Holders — by stockHoldings — by fund
Squadron Capital Management LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002050709
$322.2M
disclosed book value
38
positions
15.8%
largest position share
Positions, as of 2026-06-30
top 43 of 38 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | RLMDRELMADA THERAPEUTICS INC | 7.3M | $50.9M | 15.8% |
| 2 | CCCCC4 THERAPEUTICS INC | 7.2M | $33.6M | 10.4% |
| 3 | COGTCOGENT BIOSCIENCES INC | 865,000 | $33.5M | 10.4% |
| 4 | KODKODIAK SCIENCES INC | 500,000 | $19.5M | 6% |
| 5 | RLAYRELAY THERAPEUTICS INC | 970,000 | $18.1M | 5.6% |
| 6 | ZNTLZENTALIS PHARMACEUTICALS INC | 3.7M | $17.9M | 5.6% |
| 7 | EWTXEDGEWISE THERAPEUTICS INC | 290,000 | $11.8M | 3.7% |
| 8 | MAZEMAZE THERAPEUTICS INC | 335,000 | $10.0M | 3.1% |
| 9 | IVAINVENTIVA SA | 2.4M | $9.2M | 2.9% |
| 10 | ANLADLAI NORTYE LTD | 764,876 | $8.8M | 2.7% |
| 11 | ELVNENLIVEN THERAPEUTICS INC | 160,000 | $8.1M | 2.5% |
| 12 | AVBPARRIVENT BIOPHARMA INCCALL | 183,000 | $6.4M | 2% |
| 13 | PALIPALISADE BIO INC | 3.0M | $6.3M | 1.9% |
| 14 | BIOABIOAGE LABS INCCALL | 250,000 | $6.1M | 1.9% |
| 15 | IKTINHIBIKASE THERAPEUTICS INC | 3.0M | $6.1M | 1.9% |
| 16 | ADAGADAGENE INC | 1.3M | $5.3M | 1.6% |
| 17 | FBRXFORTE BIOSCIENCES INC | 225,000 | $4.8M | 1.5% |
| 18 | RZLTREZOLUTE INCCALL | 900,000 | $4.7M | 1.5% |
| 19 | INFLARX NV | 2.0M | $4.5M | 1.4% |
| 20 | ASMBASSEMBLY BIOSCIENCES INC | 160,000 | $4.4M | 1.4% |
| 21 | CMPSCOMPASS PATHWAYS PLCCALL | 305,000 | $4.3M | 1.3% |
| 22 | PMNPROMIS NEUROSCIENCES INC | 324,977 | $4.3M | 1.3% |
| 23 | CTNMCONTINEUM THERAPEUTICS INC | 260,000 | $4.3M | 1.3% |
| 24 | CMPSCOMPASS PATHWAYS PLC | 300,000 | $4.2M | 1.3% |
| 25 | DFTXDEFINIUM THERAPEUTICS INC | 85,000 | $4.0M | 1.2% |
| 26 | SOL-GEL TECHNOLOGIES LTD | 52,000 | $3.9M | 1.2% |
| 27 | BIOABIOAGE LABS INC | 155,000 | $3.8M | 1.2% |
| 28 | SCYXSCYNEXIS INC | 756,884 | $3.1M | 1% |
| 29 | PROQR THRAPEUTICS N V | 1.5M | $2.8M | 0.9% |
| 30 | IRONDISC MEDICINE INCCALL | 30,000 | $2.2M | 0.7% |
| 31 | RZLTREZOLUTE INC | 403,410 | $2.1M | 0.7% |
| 32 | LPCNLIPOCINE INC NEW | 810,000 | $2.1M | 0.6% |
| 33 | ZNTLZENTALIS PHARMACEUTICALS INCCALL | 426,000 | $2.1M | 0.6% |
| 34 | CCCCC4 THERAPEUTICS INCCALL | 400,000 | $1.9M | 0.6% |
| 35 | RAREULTRAGENYX PHARMACEUTICAL INCALL | 55,000 | $1.8M | 0.6% |
| 36 | CUECUE BIOPHARMA INC | 50,000 | $1.6M | 0.5% |
| 37 | CALCCALCIMEDICA INC | 1.2M | $1.3M | 0.4% |
| 38 | QNCXQUINCE THERAPEUTICS INC | 40,375 | $734,421 | 0.2% |
| 39 | NVCTNUVECTIS PHARMA INCCALL | 38,700 | $711,693 | 0.2% |
| 40 | KTTAPASITHEA THERAPEUTICS CORP | 1.0M | $515,400 | 0.2% |
| 41 | INMINMED PHARMACEUTICALS INC | 325,000 | $503,750 | 0.2% |
| 42 | NMRANEUMORA THERAPEUTICS INC. | 100,000 | $170,000 | 0.1% |
| 43 | NXTCNEXTCURE INC | 64,464 | $103,142 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.